Results 141 to 150 of about 37,488 (288)

Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins.

open access: yesJournal of Lipid Research, 1995
We have developed a procedure to quantify apolipoprotein (apo) B-100, apoB-48, and apoE in human triglyceride-rich lipoproteins. This procedure permits delipidation of small amounts of triglyceride-rich lipoproteins without appreciable losses, and ...
L Kotite, N Bergeron, R J Havel
doaj  

Apolipoprotein B [PDF]

open access: yes, 2018
K. J. Lackner, D. Peetz
openaire   +1 more source

Separation and isolation of human apolipoproteins C-II, C-III0, C-III1, and C-III2 by chromatofocusing on the Fast Protein Liquid Chromatography system

open access: yesJournal of Lipid Research, 1987
Chromatofocusing, which separates proteins based on differences in isoelectric point, has been used on the Fast Protein Liquid Chromatography (FPLC) system (Pharmacia) to separate the C apolipoproteins from human very low density lipoproteins (VLDL ...
M W Huff, W L Strong
doaj  

Lipoprotein metabolism in the ovariectomized rat.

open access: yesJournal of Lipid Research, 1983
The hyperlipoproteinemia observed after ovariectomy in rats was previously shown to be associated with increased concentrations of cholesterol, triglycerides, and apolipoproteins B, E, and C.
B J van Lenten, G W Melchior, P S Roheim
doaj  

Human apolipoprotein B: analysis of internal repeats and homology with other apolipoproteins.

open access: yesJournal of Lipid Research, 1987
Apolipoprotein B (apoB) is the major protein component of plasma low density lipoproteins (LDL) and, through its binding to the LDL receptor, it plays a prominent role in lipoprotein metabolism and in the development of atherosclerosis.
H De Loof   +5 more
doaj  

Apolipoprotein B deficiency [PDF]

open access: yesEndocrine Abstracts, 2016
Quiros Juan Manuel Garcia de   +8 more
openaire   +2 more sources

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions

open access: yesIbrain, EarlyView.
Alzheimer's disease treatment is evolving rapidly, with emerging strategies targeting multiple disease pathways. This graphical abstract highlights the shift from traditional therapies to innovative approaches that hold promise for improving outcomes.
Tapas Kumar Mohapatra   +4 more
wiley   +1 more source

Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine

open access: yesJournal of Lipid Research, 1990
Apolipoprotein B (apoB), an apolipoprotein associated with very low density lipoproteins and the atherogenic low density lipoproteins (LDL), directs the metabolism of lipoprotein particles in plasma by interacting with the LDL receptor.
JM Hoeg   +9 more
doaj  

Nosocomial infections after severe trauma are associated with lower apolipoproteins B and AII. [PDF]

open access: yesJ Trauma Acute Care Surg, 2013
Femling JK   +4 more
europepmc   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy